QUOTED. 3 February 2020. Stephen Hahn.
The new US Food and Drug Administration commissioner has outlined his top priorities for the agency, including the use of data and patient input to guide regulatory decisions, and feedback from staff on how to improve the agency. See what the agency's commissioner, Stephen Hahn, said about it here.